Facebook
Twitter
LinkedIn
Forward2022 Gene Therapy Symposium
The 2022 Gene Therapy Symposium provides an opportunity for clinicians who are committed to the care of patients with conditions that may benefit from gene therapy treatments.
Target Audience
This conference is intended for pediatricians, advanced practice providers, registered nurses, and genetic counselors.
Additional Information
| Attachment | Size |
|---|---|
 CRDT Gene Therapy Program 2022 page 1.pdf | 151.53 KB |
| CRDT Gene Therapy Program 2022 - Page 2.pdf | 116.76 KB |
November 2, 2022
8:00 a.m. to 5:00 p.m.
Please join us for a live educational program featuring presentations by these physician-researchers:
Maria Escolar, MD
UPMC Children’s Hospital of Pittsburgh
George Gittes, MD
UPMC Children’s Hospital of Pittsburgh
Dwight Koeberl, MD, PhD
DukeHealth
Charles Venditti, MD, PhD
National Institutes of Health
Jerry Vockley, MD, PhD
UPMC Children’s Hospital of Pittsburgh
Faculty Disclosure
All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All of the relevant financial relationships for the individuals listed below have been mitigated:
Jerry Vockley, MD, PhD
Grant/Research Support: Aeglea, Alexion, Arcturus, Biomarin, CoA Therapeutics, Hemoshear, Homology, LogicBio, 4D, Stealth, Nestle, PTC, Synlogic, Ultragenyx
Consultant: Biomarin, Stellite Bio, Jaguar Gene Therapy, Horizon, Frictionless Solutions, Satellite Bio, Acer, Arobio, Sanofi, PTC, Axcella, LogicBio, Sangamo, Ecrol Capital, MJH Healtcare, Illumina, Agios, Applied Therapeutics
Stockholder (privately held): American Gene Technologies, Axcella
George Gittes, MD
Consultant: Genprex
Deepa Rajan, MD
Principal Investigator in contracted research trials: Denali Therapeutics, Shire, RegenxBio, Abeona, Prevail Therapeutics
Charles Venditti, MD, PhD
Grant/Research Support: AskBio, Selecta Biosciences
Dwight Koeberl, MD, PhD
Grant/Research Support: Sangamo Therapeutics, Pharming, Viking Therapeutics, Genzyme Sanofi, Roivant Rare Diseases, Takeda
Consultant: Sangamo Therapeutics, Genzyme Sanofi, Amicus, Takeda, AskBio, and Vertex
Stockholder (privately held): AskBio
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 5.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 5.00 Attendance
This program will be free of charge for all participants. Registration is required.
Participation by all individuals is encouraged. Advance notification of any special needs will help us provide better service. Please notify us of your needs at least two weeks in advance of the program by emailing brianna.karp@chp.edu
All cancellations must be sent via email, brianna.karp@chp.edu before November 1, 2022.
For more information, please contact Brianna Karp at brianna.karp@chp.edu